Thank you! Your submission has been received, we will get back to you at the earliest convenience
Oops! Something went wrong while submitting the form.
Chord Therapeutics is a clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases. We are advancing our lead drug candidate CRD1 under orphan drug designation for the treatment of neuromyelitis optica spectrum disorders (NMO) and myasthenia gravis (MG).